Alan F. Schatzberg is an American psychiatrist. He was the 136th president of the American Psychiatric Association (2009–2010). Since 1991, he has been the Kenneth T. Norris Jr . Professor of Psychiatry and Behavioral Sciences at Stanford University School of Medicine, and he was chair of the department from 1991 to 2010. He has received multiple national and international awards for his work as an investigator in the biology and treatment of depression. He is also the co-editor-in-chief of the Journal of Psychiatric Research, along with Florian Holsboer. He received an honorary doctorate from the Medical University of Vienna in 2011.
Controversy
Alan Schatzberg, as the APA president in 2009–10, was identified as the principal investigator on a federal study into the drug mifepristone for use as an antidepressant being developed by Corcept Therapeutics, a company Schatzberg had created and in which he had several million dollars' equity.
References
- "PsychiatryOnline |". ajp.psychiatryonline.org. Archived from the original on 2012-09-28.
- ^ "Alan Schatzberg - Faculty & Researcher Profiles - Stanford School of Medicine". med.stanford.edu. Archived from the original on 2005-04-14.
- Journal of Psychiatric Research Editorial Board. Elsevier. Retrieved 2017-11-11.
- "Alan F. Schatzberg ist Ehrendoktor der MedUni Wien". Retrieved 2023-01-05.
- Viñas, Maria José (January 8, 2008). "Stanford Researcher, Accused of Conflicts, Steps Down as NIH Principal Investigator". The Chronicle of Higher Education.
External links
- Psychiatrists Propose Revisions to Diagnosis Manual. Archived 2014-01-22 at the Wayback Machine via PBS Newshour, Feb 10, 2010 (interviews Schatzberg and Allen Frances on some of the main changes proposed in the DSM-5 draft)
This article about a United States psychiatrist is a stub. You can help Misplaced Pages by expanding it. |